Serum 25-hydroxyvitamin D concentrations and risk for hip fractures
- PMID: 18711154
- PMCID: PMC2743412
- DOI: 10.7326/0003-4819-149-4-200808190-00005
Serum 25-hydroxyvitamin D concentrations and risk for hip fractures
Abstract
Background: The relationship between serum 25-hydroxyvitamin D [25(OH) vitamin D] concentration and hip fractures is unclear.
Objective: To see whether low serum 25(OH) vitamin D concentrations are associated with hip fractures in community-dwelling women.
Design: Nested case-control study.
Setting: 40 clinical centers in the United States.
Participants: 400 case-patients with incident hip fracture and 400 control participants matched on the basis of age, race or ethnicity, and date of blood draw. Both groups were selected from 39 795 postmenopausal women who were not using estrogens or other bone-active therapies and who had not had a previous hip fracture.
Measurements: Serum 25(OH) vitamin D was measured and patients were followed for a median of 7.1 years (range, 0.7 to 9.3 years) to assess fractures.
Results: Mean serum 25(OH) vitamin D concentrations were lower in case-patients than in control participants (55.95 nmol/L [SD, 20.28] vs. 59.60 nmol/L [SD, 18.05]; P = 0.007), and lower serum 25(OH) vitamin D concentrations increased hip fracture risk (adjusted odds ratio for each 25-nmol/L decrease, 1.33 [95% CI, 1.06 to 1.68]). Women with the lowest 25(OH) vitamin D concentrations (< or =47.5 nmol/L) had a higher fracture risk than did those with the highest concentrations (> or =70.7 nmol/L) (adjusted odds ratio, 1.71 [CI, 1.05 to 2.79]), and the risk increased statistically significantly across quartiles of serum 25(OH) vitamin D concentration (P for trend = 0.016). This association was independent of number of falls, physical function, frailty, renal function, and sex-steroid hormone levels and seemed to be partially mediated by bone resorption.
Limitations: Few case-patients were nonwhite women. Bone mineral density and parathyroid hormone levels were not accounted for in the analysis.
Conclusion: Low serum 25(OH) vitamin D concentrations are associated with a higher risk for hip fracture.
Summary for patients in
-
Do low vitamin D levels increase risk for hip fracture?Ann Intern Med. 2008 Aug 19;149(4):I42. doi: 10.7326/0003-4819-149-4-200808190-00002. Ann Intern Med. 2008. PMID: 18711151 No abstract available.
Similar articles
-
Do low vitamin D levels increase risk for hip fracture?Ann Intern Med. 2008 Aug 19;149(4):I42. doi: 10.7326/0003-4819-149-4-200808190-00002. Ann Intern Med. 2008. PMID: 18711151 No abstract available.
-
A combination of low serum concentrations of vitamins K1 and D is associated with increased risk of hip fractures in elderly Norwegians: a NOREPOS study.Osteoporos Int. 2016 Apr;27(4):1645-1652. doi: 10.1007/s00198-015-3435-0. Epub 2015 Dec 2. Osteoporos Int. 2016. PMID: 26630974
-
Seasonal periodicity of serum vitamin D and parathyroid hormone, bone resorption, and fractures: the Geelong Osteoporosis Study.J Bone Miner Res. 2004 May;19(5):752-8. doi: 10.1359/JBMR.040125. Epub 2004 Jan 19. J Bone Miner Res. 2004. PMID: 15068498
-
Effectiveness and safety of vitamin D in relation to bone health.Evid Rep Technol Assess (Full Rep). 2007 Aug;(158):1-235. Evid Rep Technol Assess (Full Rep). 2007. PMID: 18088161 Free PMC article. Review.
-
The serum 25-hydroxyvitamin D levels and hip fracture risk: a meta-analysis of prospective cohort studies.Oncotarget. 2017 Jun 13;8(24):39849-39858. doi: 10.18632/oncotarget.16337. Oncotarget. 2017. PMID: 28418890 Free PMC article. Review.
Cited by
-
Ablation of Vitamin D Signaling in Cardiomyocytes Leads to Functional Impairment and Stimulation of Pro-Inflammatory and Pro-Fibrotic Gene Regulatory Networks in a Left Ventricular Hypertrophy Model in Mice.Int J Mol Sci. 2024 May 29;25(11):5929. doi: 10.3390/ijms25115929. Int J Mol Sci. 2024. PMID: 38892126 Free PMC article.
-
The multi-faceted nature of age-associated osteoporosis.Bone Rep. 2024 Mar 5;20:101750. doi: 10.1016/j.bonr.2024.101750. eCollection 2024 Mar. Bone Rep. 2024. PMID: 38566930 Free PMC article. Review.
-
Effects of Isoflavonoid and Vitamin D Synergism on Bone Mineral Density-A Systematic and Critical Review.Nutrients. 2023 Dec 5;15(24):5014. doi: 10.3390/nu15245014. Nutrients. 2023. PMID: 38140273 Free PMC article. Review.
-
Infections and Autoimmunity-The Immune System and Vitamin D: A Systematic Review.Nutrients. 2023 Sep 2;15(17):3842. doi: 10.3390/nu15173842. Nutrients. 2023. PMID: 37686873 Free PMC article. Review.
-
Effects of Bazedoxifene/Vitamin D Combination Therapy on Serum Vitamin D Levels and Bone Turnover Markers in Postmenopausal Women with Osteopenia: A Randomized Controlled Trial.J Bone Metab. 2023 May;30(2):189-199. doi: 10.11005/jbm.2023.30.2.189. Epub 2023 May 31. J Bone Metab. 2023. PMID: 37449351 Free PMC article.
References
-
- Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev. 2001;22(4):477–501. - PubMed
-
- Looker AC, Dawson-Hughes B, Calvo MS, Gunter EW, Sahyoun NR. Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone. 2002;30(5):771–7. - PubMed
-
- Thomas MK, Lloyd-Jones DM, Thadhani RI, et al. Hypovitaminosis D in medical inpatients. N Engl J Med. 1998;338(12):777–83. - PubMed
-
- LeBoff MS, Kohlmeier L, Hurwitz S, Franklin J, Wright J, Glowacki J. Occult vitamin D deficiency in postmenopausal US women with acute hip fracture. JAMA. 1999;281(16):1505–11. - PubMed
-
- Cranney A, Horsley T, O'Donnell T, et al. Evidence Report/Technical Assessment No. 158 (Prepared by the Univerisity of Ottawa Evidence-based Practice Center (UOEPC) under Contract No 290−02−0021. Agency for Healthcare Research and Quality. .; Rockville, MD: 2007. Effectiveness and safety of Vitamin D in relation to bone health. AHRQ Publication No. 07-E013.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical